Senior Director, Pricing and Market Access, Europe

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, European Pricing & Market Access serves as the regional pricing leader and European pricing voice for Revolution Medicines. This incumbent will be a senior member of the European Market Access Leadership Team and acts as the dedicated European pricing strategist, providing rapid-response pricing scenario capability at product, indication, and portfolio level to support negotiations, pricing g...